The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

Some 20 travel staff at the FDA, who made arrangements for the regulator’s inspectors, will be getting their jobs back, as ...

Too easily overlooked are non-influenza, non-COVID viruses and bacteria that are burgeoning and spreading unchecked — both in ...

FRIDAY, May 2, 2025 (HealthDay News) — U.S. Health and Human Services Secretary Robert F. Kennedy Jr. plans to change how ...

COVID-19 booster is here, and public health officials are urging seniors and immunocompromised people to get protected ahead ...

Five years after the worldwide hyperfocus on COVID-19 began, some are concerned about the next pandemic — whether it could be ...

Hartford- based Aetna plans to pull out of Affordable Care Act health-insurance exchanges nationwide next year, parent company CVS Health announced on Thursday. "We're disappointed by the continued ...

The market expects ANI Pharmaceuticals (ANIP) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus ...